文献速递临床试验与 GCP基础与转化研究

心脏手术中的多模式心脏保护策略(ProCCard试验):多中心随机对照试验研究方案

Multimodal cardioprotective strategy in cardiac surgery (the ProCCard trial): Study protocol for a multicenter randomized controlled trial.
PubMed 文献 · Trials · 2019-09-11

ProCCard试验为法国六家机构开展的前瞻性、随机、单盲、对照研究方案,拟纳入210例主动脉瓣手术(伴或不伴冠状动脉旁路移植术)患者,随机分为对照组(丙泊酚全静脉麻醉+宽松血糖管理)与治疗组(五项心脏保护措施组合),主要结局为术后72小时高敏肌钙蛋白I曲线下面积。

要点

  • 治疗组接受五项心脏保护措施组合:远程缺血预处理、七氟烷维持麻醉、严格血糖管理、心肺转流结束时的中度呼吸性酸中毒及温和再灌注方案。
  • 对照组接受丙泊酚全静脉麻醉,每60分钟测血糖,超过180 mg/dl时启动胰岛素输注。
  • 治疗组每30分钟测血糖,超过140 mg/dl时启动胰岛素输注。

核心结论

  • ProCCard研究将是首个评估多种心脏保护策略组合对心肺转流心脏手术患者心肌损伤作用的多中心随机对照试验。

研究设计与样本

  • 务实性多中心(法国六家机构)、前瞻性、随机、单盲、对照试验,按中心分层随机。
  • 拟纳入210例择期主动脉瓣手术伴或不伴冠状动脉旁路移植术患者,对照组与治疗组各105例。

主要发现

  • 对照组接受丙泊酚全静脉麻醉,每60分钟测血糖,血糖大于180 mg/dl时启动胰岛素输注,作为标准治疗。
  • 治疗组接受五项心脏保护措施组合:主动脉阻断前远程缺血预处理、七氟烷维持麻醉、每30分钟测血糖且大于140 mg/dl时启动胰岛素输注的严格血糖管理、心肺转流结束时中度呼吸性酸中毒(pH 7.30)、主动脉开放后温和再灌注方案。
  • 主要结局为术后72小时高敏肌钙蛋白I曲线下面积评估的心肌损伤。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Myocardial damage in patients undergoing cardiac surgery increases both morbidity and mortality. Different protective strategies dealing with either preconditioning or postconditioning or assessing a single aspect of cardioprotection have shown conflicting results. We tested the hypothesis that a multimodal approach would improve cardioprotection and limit myocardial damage following cardiac surgery with cardiopulmonary bypass. METHODS: This study is a pragmatic multicenter (six French institutions), prospective, randomized, single-blinded, controlled trial. The randomization is stratified by centers. In the study, 210 patients scheduled for aortic valve surgery with or without coronary artery bypass grafting will be assigned to a control or a treatment group (105 patients in each group). In the control group, patients receive total intravenous anesthesia with propofol and liberal intraoperative blood glucose management (initiation of insulin infusion when blood glucose, measured every 60 min, is greater than 180 mg/dl), as a standard of care. The treatment group receives a bundle of care combining five techniques of cardioprotection: (1) remote ischemic preconditioning applied before aortic cross-clamping; (2) maintenance of anesthesia with sevoflurane; (3) tight intraoperative blood glucose management (initiation of insulin infusion when blood glucose, measured every 30 min, is greater than 140 mg/dl); (4) moderate respiratory acidosis (pH 7.30) at the end of cardiopulmonary bypass; and (5) a gentle reperfusion protocol following aortic unclamping. The primary outcome is myocardial damage measured by postoperative 72-h area under the curve of high-sensitivity cardiac troponin I. DISCUSSION: The ProCCard study will be the first multicenter randomized controlled trial aiming to assess the role of a bundle of care combining several cardioprotective strategies to reduce myocardial damage in patients undergoing cardiac surgery with cardiopulmonary bypass. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03230136 . Registered on July 26, 2017. Last updated on April 17, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chiari P, Durand M, Desebbe O, et al. Multimodal cardioprotective strategy in cardiac surgery (the ProCCard trial): Study protocol for a multicenter randomized controlled trial. Trials. 2019. PMID: 31511041. doi:10.1186/s13063-019-3638-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。